Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 568

Document Document Title
JP5821132B2
The present invention relates to eukaryotic cells which have the ability to isomerise xylose directly into xylulose. The cells have acquired this ability by transformation with nucleotide sequences coding for a xylose isomerase that has ...  
JP5796925B2
The present invention relates to genetic modifications in eukaryotic host cells that have been transformed to express a xylose isomerase that confers on the host cell the ability to isomerize xylose to xylulose. These genetic modificatio...  
JP5762702B2
The uses is claimed of: (i) aerogels (AG) for adsorption from a liquid phase; (ii) hydrophilic or hydrophobic AG as adsorbents; and (iii) adsorbents containing AG (not as a mixture with activated carbon or active alumina) for adsorption ...  
JP2015070856A
To provide a yeast capable of conducting alcoholic fermentation and using xylose as a carbon source.The present invention relates to host cells transformed with a nucleic acid sequence encoding a eukaryotic xylose isomerase obtainable fr...  
JP2014087365A
To provide a method of applying a chemically defined formulation in industrial scale fermentation, in order to avoid problems associated with a usual use method of a composite culture medium in the current industrial site.Use of a chemic...  
JP5261709B2
To provide a method for adding a fatty acid to an amino acid, a peptide and a protein by an enzymatic means, in an aqueous solution. This method for producing a fatty acid-added amino acid or fatty acid-added amino acid derivative, fatty...  
JP2013055948A
To provide eukaryotic host cells, such as fungal host cells, that are transformed with an XI gene that confers the ability to grow on xylose and which host cells have specific rates of xylose consumption and/or product (ethanol) formatio...  
JP5113800B2
The present invention relates to host cells transformed with a nucleic acid sequence encoding a eukaryotic xylose isomerase obtainable from an anaerobic fungus. When expressed, the sequence encoding the xylose isomerase confers to the ho...  
JP5022913B2
The present invention relates to a process for the synthesis of cefaclor, which process comprises reacting 7-amino-3-chloro cephalosporanic acid (7-ACCA) with D-phenylglycine in activated form (PGa) in the presence of an enzyme in a reac...  
JP4659111B2  
JP4598333B2
The present invention relates to a process for delaying the deactivation of glutaryl amidase during enzyme catalysis. The enzyme catalyst is, after maximum conversion of the substrate, separated off by filtration and can be reused in a s...  
JP4469401B2
The present invention describes the use of chemically defined media for the fermentative production of valuable compounds on an industrial scale. Microbial strains which are suitable for fermentation on an industrial scale using a chemic...  
JP2010516800A
The invention relates to novel antimicrobial agents that are based on β-lactam derivatives and are produced by reacting previously known β-lactam derivatives with polyphenol oxidase substrates under the influence of free radicals and b...  
JP4334352B2
The present invention relates to host cells transformed with a nucleic acid sequence encoding a eukaryotic xylose isomerase obtainable from an anaerobic fungus. When expressed, the sequence encoding the xylose isomerase confers to the ho...  
JP2009195254A
To apply a chemically defined treatment in an industrial scale fermentation in order to avoid problems associated with usual methods of using complex media in the present industrial scenes.The use of chemically defined media for fermenta...  
JP4217277B2
The present invention describes the use of chemically defined media for the fermentative production of valuable compounds on an industrial scale. Microbial strains which are suitable for fermentation on an industrial scale using a chemic...  
JP4147319B2
New mutant beta -lactam Penicillin G acylases are provided, exhibiting altered substrate specificities. These Penicillin G acylases are obtained by expression of a gene encoding said Penicillin G acylase and having an amino acid sequence...  
JP4080542B2
New mutant penicillin G acylases preferably from E. coli are provided, exhibiting altered enzymatic activity. These penicillin G acylases are obtained by expression of a gene encoding said penicillin G acylase having an amino acid sequen...  
JPWO2005075652A1
A modified peptide (ie, modified) with enhanced glutaryl-7-aminocephalosporanic acid (GL-7-ACA) acylase activity using γ-glutamyl transpeptidase (GGT), an enzyme widely distributed in the biological world. It is an object of the present...  
JP3889438B2
The present invention relates to an enzyme process for the one-step conversion of cephalosporin C or a derivative thereof into 7-aminocephalosporanic acid or a corresponding derivative thereof. The one step conversion is effected using a...  
JP2007502108A
A CPC acylase mutant of the present invention has an improved reactivity and specific activity to CPC, which can be efficiently employed for directly preparing 7-ACA from CPC by a one-step enzymatic method.  
JP3856807B2
To provide a beta-lactamase as a reporter gene, a beta-lactamase substrate compound and uses thereof for particularly monitoring expression from a pair of expression control sequences to screen a biochemical activity. Disclosed is a reco...  
JP2006514542A
The present invention relates to isolated nucleic acid molecules which code for a new protein from Acremonium chrysogenum, to vectors which comprise such a nucleic acid molecule, to Acremonium chrysogenum host cells which have been trans...  
JP2006500957A
The invention relates to a process for the preparation of cephalexin with the aid of a penicillin amidase immobilized on a crosslinked hydrophilic copolymer which has binding activity for ligands having nucleophilic groups and is in bead...  
JP2005348743A
To provide a catalytic process for enzymatically producing 7-aminocephalosporanic acid (7-ACA) in the absence of esterase activity.Disclosed is a process for decreasing esterase activity present in the presence of D-amino acid oxidase ac...  
JP2005536225A
The present invention discloses a bioreactor apparatus with an expandable surface area which is useful for culturing cells. A method for culturing cells is also included in the invention. The method comprises providing a container and a ...  
JP2005525102A
This invention provides amidases, polynucleotides encoding the amidases, methods of making and using these polynucleotides and polypeptides. In one aspect, the invention provides enzymes having secondary amidase activity, e.g., having ac...  
JP2005198655A
To provide an enzyme having a cephalosporin C acylase activity, a method of recombining a DNA for preparing the enzyme, a nucleotide sequence encoding the enzyme, an expression vector including the nucleotide sequence, a cell transformed...  
JP3633940B2
Substrates for beta -lactamase of general formula (I) in which one of X and Y is a fluorescent donor moiety and the other is a quencher (which may or may not re-emit); R' is selected from the group consisting of H, lower (i.e. alkyl of 1...  
JP2004538265A
A process for preparing cephalosporanic acid derivatives comprises the steps of enzymatically converting a 3-thiolated cephalosporin C compound of formula III:- into a 3-thiolated-alpha-ketoadipyl-7-aminocephalosporanic acid derivative o...  
JP2004537985A
A process for preparing cephalosporanic acid derivatives comprises the steps of enzymatically converting a 3-thiolated cephalosporin C compound of formula III:- into a 3-thiolated-alpha-ketoadipyl-7-aminocephalosporanic acid derivative o...  
JP3601846B2  
JP3574453B2
PCT No. PCT/EP94/02544 Sec. 371 Date May 13, 1996 Sec. 102(e) Date May 13, 1996 PCT Filed Jul. 29, 1994 PCT Pub. No. WO95/04149 PCT Pub. Date Feb. 9, 1995An overall efficient process for the preparation and recovery of 7-aminodesacetoxyc...  
JP2004524006A
The invention provides a glutaryl 7-ACA amidase from Pseudomonas diminuta strain BS-203, which catalyzes the hydrolysis of 7-beta-(4-carboxybutanamido)-cephalosporanic acid to 7-aminocephalosporanic acid and glutaric acid. The invention ...  
JP2004501619A
A process for the preparation of biologically active compounds, wherein active substances having additional functional groups and a modified spectrum of activity and modified application properties are obtainable from medicinal substance...  
JP2004500826A
The present invention concerns the direct production of desacetylcephalosporin C by culturing a strain of Acremonium chrysogenum containing recombinant nucleic acid encoding Rhodosporidium toruloides cephalosporin esterase.  
JP3476834B2
Process for producing the enzyme D-amino acid oxydase of Rhodotorula gracilis in host cells. The process for the expression of the enzyme comprises isolating the complementary DNA corresponding to the messager RNA of the gene which codes...  
JP3471393B2
PURPOSE: To control the size of a granule of a mold, increase the mass transfer rate of oxygen, a substrate, etc., enable the improvement in productivity of useful substances and further application to an efficient microbial treatment pr...  
JP2003527069A
The invention provides DNA, heterologous host cells capable of transcribing, translating or expressing said DNA and methods employing such host cells and cultures thereof for an improved in vivo production of acylated cephalosporins with...  
JP3404406B2
PURPOSE: To obtain an Escherichia coli recombinant strain capable of producing- glutaryl-7ACA-acylase, substantially containing no β-lactamase activity to decompose 7-aminocephalosporanic acid. CONSTITUTION: Recombinant DNA technology r...  
JP2003512039A
The invention relates to the production of secondary metabolites by fungi. More particularly, the invention relates to improvement of production of commercially important secondary metabolites by fungi. The invention provides methods for...  
JP2002541812A
An extracellular protease of Acremonium chrysogenum with CPC-acetylhydrolase activity and its use for the synthesis of deacetylated derivatives of cephalosporin C and inactivation of the gene for increasing the yield of cephalosporin. Th...  
JP2002316991A
To provide the penicillin and cephalosporin causing no enzyme inhibition.The objective penicillin and cephalosporin includes phenylacetic acid or phenoxyacetic acid in an amount of ≤100 ppm.  
JP2002533092A
The present invention discloses a process for the production of 7-amino cephalosporanic acid (7-ACA) or a derivative thereof comprising the steps of fermenting a P. chrysogenum strain being transformed with an expression construct compri...  
JP3321107B2
DNA sequences obtained from S. clavuligerus ATCC 27064, recombinant vectors incorporating such sequences and hosts transformed with such vectors are disclosed. The DNA comprises one or more genes coding for one or more enzymes involved i...  
JP2002509933A
A method for the recovery of an N-substituted cephalosporanic acid compound of general formula (I), wherein R2 is selected from the group consisting of adipyl (1,4-dicarboxybutane), succinyl, glutaryl, adipyl, pimelyl, suberyl, 2-carboxy...  
JP2002509933A5  
JP2002501750A
The present invention relates to a nucleic acid molecule which codes for the cephalosporin acetylesterase from Bacillus subtilis ATCC 6633 (DSM 11909), vectors and host cells which comprise such a nucleic acid molecule, a process for the...  
JP2002500015A
Three-dimensional crystal structure(s) of deacetoxycephalosporin C synthase (DAOCS) are described. The X-ray co-ordinates provide precise 3-dimensional information of amino acids within the structure of DAOCS. Some of these are in comple...  
JP2002000266A
To provide an immobilized enzyme capable of industrially hydrolyzing 7-aminocephalosporanic acid in high efficiency.The immobilized enzyme is acetyl hydrolase derived from Bacillus subtilis and immobilized on N,N'-methylene-bis(methacryl...  

Matches 151 - 200 out of 568